N/A
Completed N=452
A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters
Peripheral Vascular Diseases · Thrombosis · venous thrombosis
Source: ClinicalTrials.gov NCT00778336 ↗
Enrolled (actual)
452
Serious AEs
1.8%
Results posted
Apr 2011
Primary outcomePrimary: Change From Baseline to Final Angiographic Results — 1.32; 1.37; 1.16; 1.89 Occlusion Index — p=<0.0001
Summary
This registry collects observational data about how mid-length AngioJet catheters (ie XPEEDIOR and DVX models) are used in routine clinical practice.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline to Final Angiographic Results |
1.32; 1.37; 1.16; 1.89; 3.67; 3.67 | <0.0001 sig |
| SECONDARY Rethrombosis |
17; 11; 14; 0 | — |
| SECONDARY Description of Treatments by Thrombotic Condition |
70; 78; 68; 6; 121; 144 | — |
Eligibility Criteria
Inclusion Criteria
- Patient has been treated with a mid-length AngioJet catheter(defined as 90-120 cm in length)
- Patient has provided appropriate authorization per institutional policy and procedure.
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT00778336). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.